Madrigal Pharmaceuticals: Canaccord Genuity raises target price to $633 from $612
MDGL•Canaccord Genuity raised its target price for Madrigal Pharmaceuticals to $633 from $612.
Related News
Freshworks Inc.: Canaccord Genuity raises target price to $17 from $15
FRSH•
Revvity, Inc.: Leerink Partners raises target price to $180 from $160
RVTY•
Scotiabank raises Amgen target price to $530 from $500
AMGN•
Booking Holdings: RBC cuts target price to $205 from $220
BKNG•
Expeditors International of Washington raises target price to $240 from $220
EXPD•